Drug Patents owned by Eton
1. List of Alkindi Sprinkle drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9717740 | ETON | Treatment of adrenal insufficiency |
Nov, 2032
(9 years from now) | |
| US9675559 | ETON | Treatment of adrenal insufficiency |
Jan, 2033
(9 years from now) | |
| US9649280 | ETON | Composition comprising hydrocortisone |
May, 2034
(11 years from now) | |
Drugs and Companies using HYDROCORTISONE ingredient
Market Authorisation Date: 29 September, 2020
Treatment: Treatment of adrenal insufficiency
Dosage: GRANULE;ORAL
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic